Revenue Potential with LipiFlow and LipiScan

Patients seen per week

Low High

% of patients screened for MGD

Low High

Conversion rate goal

Low High

Revenue per procedure

Low High

Adjust these values to see the impact on potential patient volume, suggested charges, and estimated revenue for LipiFlow.

info Created with Sketch. More information on these products

Potential LipiFlow candidates in your practice*

Suggested charge per LipiFlow Procedure

Suggested charge per LipiScan and LipiFlow Procedure

Patients per week
14 LipiFlow, 60 LipiScan


Gross profit
$1,500/wk, $78,000/yr

Your break-even point
2.14 months


Gross profit
$8,640/wk, $449,280/yr

Your break-even point
0.61 months



Email Address*

Zip Code*

Comment (optional)


These tools were developed to help you decide whether purchasing this device makes sense for your practice setting. Sample values are already entered in the calculator fields, but you can adjust them to reflect your circumstances. This tool reflects average values of the requisite factors associated with operation of these devices in bilateral procedures, but does not include chair time and/or follow up visits. Additionally, incorporation of this technology may require startup costs such as physical space allocation, tables, staff training, advertising materials/digital assets, and other miscellaneous costs. You should consider all variables when contemplating the purchase of this or any device.

*Results based on findings that up to 60% of the population has MGD.

1. Blackie C, Carlson AN, Korb DR. Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review. Current Opinion in Ophthalmology. 2015; 26(4):306-13.